During the past decade, Hospital Virgen de la Luz conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Virgen de la Luz" #1 sponsor was "PETHEMA Foundation" with 4 trials, followed by "Spanish Breast Cancer Research Group" with 4 trials sponsored, "Spanish Lung Cancer Group" with 4 trials sponsored, "Dr. Negrin University Hospital" with 3 trials sponsored and "Cancer Trials Ireland" with 3 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Virgen de la Luz" #1 collaborator was "Asociación Científica Pulmón y Ventilación Mecánica" with 3 trials as a collaborator, "AECC_Asociación Española contra el Cáncer" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "Consorcio Centro de Investigación Biomédica en Red (CIBER)" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Virgen de la Luz" are "Multiple Myeloma" (3 trials), "Non Small Cell Lung Cancer" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials) and "Acute Respiratory Distress Syndrome (ARDS)" (1 trials). Many other conditions were trialed in "Hospital Virgen de la Luz" in a lesser frequency.

Most popular intervention types in "Hospital Virgen de la Luz" are "Drug" (11 trials), "Other" (2 trials), "Device" (1 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (2 trials), "Paclitaxel" (2 trials), "Prednisone" (2 trials), "Asparaginase" (1 trials) and "Conventional Lung Protective Ventilation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Virgen de la Luz" are 19 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Virgen de la Luz". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Hospital Virgen de la Luz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Virgen de la Luz, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".